Solara Active Pharma Sciences Limited

NSEI:SOLARA 주식 보고서

시가총액: ₹26.2b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Solara Active Pharma Sciences 미래 성장

Future 기준 확인 4/6

Solara Active Pharma Sciences (는) 각각 연간 141.2% 및 12% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 106.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 7.5% 로 예상됩니다.

주요 정보

141.2%

수익 성장률

106.3%

EPS 성장률

Pharmaceuticals 수익 성장17.1%
매출 성장률12.0%
향후 자기자본 수익률7.5%
애널리스트 커버리지

Low

마지막 업데이트19 Jun 2024

최근 미래 성장 업데이트

Recent updates

Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

Jun 05
Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

May 11
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Apr 19
Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Mar 13
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Feb 23
Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Jan 04
Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

May 12
Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Nov 08
Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Sep 30
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Aug 03
Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Jun 19
Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

Feb 17
Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Dec 21
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

With EPS Growth And More, Solara Active Pharma Sciences (NSE:SOLARA) Is Interesting

Oct 28
With EPS Growth And More, Solara Active Pharma Sciences (NSE:SOLARA) Is Interesting

수익 및 매출 성장 예측

NSEI:SOLARA - 애널리스트의 미래 추정치 및 과거 재무 데이터 (INR Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
3/31/202718,904N/AN/AN/A1
3/31/202617,813942N/A2,0371
3/31/202516,2064171,0248451
3/31/202412,889-5,6746781,089N/A
12/31/202314,069-3,077N/AN/AN/A
9/30/202315,529-3255341,511N/A
6/30/202314,661-253N/AN/AN/A
3/31/202314,438-2224491,563N/A
12/31/202214,240-241N/AN/AN/A
9/30/202211,296-1,644-1,527-222N/A
6/30/202211,928-1,247N/AN/AN/A
3/31/202212,683-581-4,506-2,420N/A
12/31/202113,517-34N/AN/AN/A
9/30/202116,7812,023-3,236-953N/A
6/30/202116,7402,293N/AN/AN/A
3/31/202116,1692,214-1901,555N/A
12/31/202014,6941,826N/AN/AN/A
9/30/202013,8641,5812912,634N/A
6/30/202013,4001,304N/AN/AN/A
3/31/202013,2181,146-2672,422N/A
12/31/201914,1031,231N/AN/AN/A
9/30/201914,2281,0391,4942,839N/A
6/30/201914,140845N/AN/AN/A
3/31/201913,8676141,0731,663N/A
3/31/20185,21060145492N/A

애널리스트 미래 성장 예측

수입 대 저축률: SOLARA 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 6.7% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: SOLARA (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: SOLARA 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: SOLARA 의 수익(연간 12% ) Indian 시장( 9.5% 보다 빠르게 성장할 것으로 예상됩니다. 9.5% 연간).

고성장 수익: SOLARA 의 수익(연간 12% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: SOLARA 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 7.5 %).


성장 기업 발견